Accès ouvert
2026
erratum
OpenAlex
Qianyu Jing, Quan Wan, Yujie Nie, Junqian Luo et autres
Colon cancer (CRC) is the fourth deadliest cancer worldwide, killing hundreds of thousands of people each year (1). At the same time, the mental health of patients is also attracting more and more attention, with the occurrence of depression in cancer patients …
cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Qianyu Jing, Junqian Luo, Quan Wan, Qianjun Jing et autres
Introduction: Immunotherapy is considered the most promising approach for achieving complete tumor clearance in cancer treatment. However, monotherapy has demonstrated limited clinical efficacy, leading to a growing consensus that combination immunotherapy-activating the immune system through multiple pathways-appears to be the optimal strategy …
cn, hk
(code pays fourni par la source)
2026
article
OpenAlex
Shengwen Zhou, Linjian Xia, Liming Zhao, Jia Song et autres
cn, hk
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xiefei Hu, Chunmei Duan, Huajian Chen, Xun Li et autres
BACKGROUND: Influenza A (IAV) and B (IBV) viruses are the primary etiologic agents driving seasonal influenza epidemics and global pandemics. Early prediction plays a crucial role in epidemic control and reducing mortality rates. Complete blood count (CBC), a widely used clinical tool, …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Yujie Nie, Huan Gui, Haohua Yuan, Qianyu Jing et autres
cn, hk
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Hang Lv, Yujie Nie, Huan Gui, Haohua Yuan et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Zhi Li, Yidi Guan, Jie Gao, Lan Zhu et autres
cn
(code pays fourni par la source)
2024
article
OpenAlex
Huan Gui, Yujie Nie, Haohua Yuan, Mengjiao Wang et autres
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Huan Gui, Yujie Nie, Haohua Yuan, Qianyu Jing et autres
Lung cancer is increasingly recognized as a leading cause of cancer‑related mortality. Immunotherapy has emerged as a promising therapeutic approach for lung cancer, particularly non‑small cell lung cancer (NSCLC). Nonetheless, the response rate to programmed cell death 1 (PD‑1) inhibitors remains less …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Haohua Yuan, Huan Gui, Shuanghui Chen, Lan Zhu et autres
Purpose: This study aimed to develop a novel and feasible modification strategy to improve the solubility and antitumor activity of resiquimod (R848) by utilizing the supramolecular effect of 2-hydroxypropyl-beta-cyclodextrin (2-HP-β-CD). Methods: R848-loaded PLGA nanoparticles modified with 2-HP-β-CD (CD@R848@NPs) were synthesized using an …
cn
(code pays fourni par la source)
2024
article
OpenAlex
Mengjiao Wang, Quan Wan, Chenglv Wang, Qianyu Jing et autres
cn, hk, mo, us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Huan Gui, Yujie Nie, Haohua Yuan, Linzhao Li et autres